These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11187110)

  • 1. Costs decline with HAART.
    AIDS Patient Care STDS; 2000 Dec; 14(12):672. PubMed ID: 11187110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaco-economic aspects of HIV therapy. Savings with HAART].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():80. PubMed ID: 15011600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.
    Beck EJ; Mandalia S; Gaudreault M; Brewer C; Zowall H; Gilmore N; Klein MB; Lalonde R; Piché A; Hankins CA
    AIDS; 2004 Dec; 18(18):2411-8. PubMed ID: 15622317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.
    Corzillius M; Mühlberger N; Sroczynski G; Jaeger H; Wasem J; Siebert U
    Antivir Ther; 2004 Feb; 9(1):27-36. PubMed ID: 15040534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study: HAART less costly than treatment for AIDS. Annual health care cost lowered by 31%.
    AIDS Alert; 2001 Feb; 16(2):26-7. PubMed ID: 15446225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to balance the antiretrovirus drugs and cost in China].
    Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1153-4. PubMed ID: 22882999
    [No Abstract]   [Full Text] [Related]  

  • 10. Specialists drive success of AIDS disease management.
    Healthc Demand Dis Manag; 1997 Jun; 3(6):81-5. PubMed ID: 10174900
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral therapy is only part of it.
    Mbewu A
    Bull World Health Organ; 2001; 79(12):1152. PubMed ID: 11842785
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost of AIDS and HIV infection: the experience of a public hospital in the context of national forecasts.
    Rietmeijer CA
    Compr Ther; 1993; 19(4):174-6; quiz 177-81. PubMed ID: 7903233
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct costs of HIV/AIDS care.
    Levy AR; James D; Johnston KM; Hogg RS; Harrigan PR; Harrigan BP; Sobolev B; Montaner JS
    Lancet Infect Dis; 2006 Mar; 6(3):171-7. PubMed ID: 16500598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAART less costly.
    AIDS Patient Care STDS; 2001 May; 15(5):289-90. PubMed ID: 11530771
    [No Abstract]   [Full Text] [Related]  

  • 16. AIDS could dominate Russian budget by 2020.
    Walgate R
    Bull World Health Organ; 2002; 80(8):686-7. PubMed ID: 12219165
    [No Abstract]   [Full Text] [Related]  

  • 17. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
    Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
    J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
    Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS--will the next 20 years be different?
    Steinbrook R; Drazen JM
    N Engl J Med; 2001 Jun; 344(23):1781-2. PubMed ID: 11396446
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS is your business.
    Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
    Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.